Drug intelligence / Profile preview

Yan-Ling-Yi-Shou Decoction

Development stage: Preclinical
Lead developer: Jiangsu Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Yan-Ling-Yi-Shou Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Affiliated Hospital of Nanjing University of Chinese Medicine. It is primarily investigated for the treatment of chronic fatigue syndrome (CFS), specifically targeting the heart and spleen deficiency subtype in TCM diagnosis. The decoction is often evaluated in clinical settings either as a monotherapy or in combination with graded exercise therapy (GET) to improve clinical symptoms and safety profiles in adult patients.

Other names: Yanling Yishou Decoction

Beyond the preview

Go deeper on Yan-Ling-Yi-Shou Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yan-Ling-Yi-Shou Decoction.

Explore the full profile